Burden and socioeconomics of asthma, allergic rhinitis, atopic dermatitis and food allergy

Abstract

Introduction: Asthma, allergic rhinitis, atopic dermatitis, and food allergy affect approximately 20% of the global population. Few studies describe the burden of the totality of these diseases and only a handful studies provide a comprehensive overview of the socioeconomic impact of these diseases. Areas covered: For this narrative review, we searched Pubmed using selected keywords and inspected relevant references using a snowballing process. We provide an overview of the socioeconomic burden of allergic diseases (in particular, asthma, allergic rhinitis, atopic dermatitis, and food allergy). The focus of this review is on their epidemiology (incidence, prevalence), burden (disability-adjusted life years, quality of life), and direct and indirect costs (absenteeism and presenteeism). We have put special emphasis on differences between countries. Expert commentary: Both the prevalence and the burden of allergic diseases are considerable with prevalence varying between 1% and 20%. We identified a plethora of studies on asthma, but studies were generally difficult to compare due to the heterogeneity in measures used. There were only few studies on the burden of food allergy; therefore, more studies on this allergy are required. For future studies, we recommend standardizing epidemiologic, socioeconomic impact, and quality of life measures of allergic diseases.

Impact of Probiotic Bacteria on Respiratory Allergy Disorders

“…On the other hand, a significant percentage of patients with rhinitis symptoms try to self-medicate and select their drugs in a pharmacy shop based on the marketing advertisements, family/friend suggestion and others ( Tan et al, 2017 ). The costs related to health care and temporary disability due to allergic diseases are increasing significantly worldwide ( Dierick et al, 2020 ). The term ‘respiratory allergy’ generally describes the group of symptoms appearing after inhaling allergens.…”

Work absence in patients with asthma and/or COPD: a population-based study

“…Furthermore, it was shown that in asthma patients with comorbidities, productivity loss was even 1.5 times higher than in asthma patients without comorbidity 15 . In a recent review 16 , it was highlighted that asthma patients have a considerable health-related productivity loss, up to 20.9% of the time an asthma patient worked.…”

S100A4 Is Critical for a Mouse Model of Allergic Asthma by Impacting Mast Cell Activation

“…Allergy is one of the most prevalent human diseases affecting the quality of life of about 20% of the global population, the incidence of which has been steadily increasing over the past decades. This increasing trend is particularly notable for allergic asthma and rhinitis, which has led to an enormous socioeconomic burden worldwide (1). Currently more than 300 million people suffer from asthma globally, and this number may likely be increased by another one third by 2025 (2).…”